Stockreport

Salarius Pharmaceuticals to Attend the Oppenheimer Healthcare Conference

Salarius Pharmaceuticals, Inc.  (SLRX) 
PDF HOUSTON, March 02, 2020 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage oncology company targeting cancers caused by dysregulated g [Read more]